Impressively, for doxorubicin-induced senescent breast tumor cell line MDA-MB-231, Rh2 not only suppressed the accepted p38MAPK and NF-κB pathways but also prohibited Stat3 pathway. This evidence concerns the gene STAT3 and breast neoplasm.